Susmed has achieved a milestone in its sales partnership with Shionogi & Co., Ltd., and started sales of the sleep disorder app from June 1. Detailed revenue and figures are yet to be finalized.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4263","jir_company_name":"Susmed Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-06-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/06\/4263-20260605-01.pdf","jir_short_summary":"Susmed has achieved a milestone in its sales partnership with Shionogi & Co., Ltd., and started sales of the sleep disorder app from June 1. Detailed revenue and figures are yet to be finalized.","jir_summary":"### Sales Partnership and Milestone Achievement\nSusmed has achieved the set milestone within its sales partnership with Shionogi & Co., Ltd. This has led to progress toward insurance coverage and sales initiation, with detailed revenue and figures to be disclosed after further discussion. The sales of the sleep disorder app began on June 1, focusing on dissemination to medical institutions and patients.\n\n### Future Outlook and Impact on Shareholders\nWith the progress of the sales partnership, expectations for future revenue generation and market expansion are high, though detailed revenue and sales forecasts have not yet been announced. Ongoing discussions are in progress; once sales figures and revenue are confirmed, information will be disclosed as appropriate. For shareholders, the progression of the partnership and sales launch could contribute to increased corporate value.","jir_financial_highlights":"Sales Start Date: 2026-06-01 (Unknown)\nMilestone Achievement Date: 2026-05-13 (Unknown)\nSales Partnership Agreement Date: 2021-12-27 (Unknown)","jir_category":"","jir_hashtags":"#Susmed, #IRRelated, #JapanStocks","jir_key_figures":"Sales Start Date: 2026-06-01\nMilestone Achievement Date: 2026-05-13\nSales Partnership Signing Date: 2021-12-27","jir_meta_title":"\u3010Susmed\u3011Sales Partnership Milestone Achieved | June 2026","jir_meta_description":"Susmed has achieved a milestone in its sales partnership with Shionogi & Co., Ltd., and started sales of the sleep disorder app from June 1. Details will be announced in the future.","jir_og_title":"\u3010Susmed\u3011Partnership Achievement and Sales Launch | June 2026","jir_og_description":"Susmed has achieved a milestone through its partnership with Shionogi & Co., Ltd., and has launched sales of the sleep disorder app. Stay tuned for future developments.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":58337,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-61792","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n